Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:22 pm Sale | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | ORBIMED ADVISORS LLC | 0 0.000% | -25,431 (Position Closed) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | Standard BioTools Inc. LAB | ORBIMED ADVISORS LLC | 3,416,871 4.460% | -82,375 (-2.35%) | Filing History |
| 2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | ORBIMED ADVISORS LLC | 3,196,876 6.700% | 443,309 (+16.10%) | Filing History |
| 2022-02-11 4:18 pm Purchase | 2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | ORBIMED ADVISORS LLC | 342,423 4.300% | 342,423 (New Position) | Filing History |
| 2022-02-11 4:14 pm Purchase | 2021-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 2,100,681 8.000% | 433,856 (+26.03%) | Filing History |
| 2022-02-11 4:12 pm Sale | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ORBIMED ADVISORS LLC | 158,245 7.900% | -42,376 (-21.12%) | Filing History |
| 2022-02-11 4:10 pm Sale | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | ORBIMED ADVISORS LLC | 0 0.000% | -484,525 (Position Closed) | Filing History |
| 2022-02-02 4:33 pm Unchanged | 2022-01-31 | 13D | Sierra Oncology, Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 15.300% | 0 (Unchanged) | Filing History |
| 2021-12-17 5:08 pm Purchase | 2021-12-16 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 2,649,464 6.400% | 2,649,464 (New Position) | Filing History |
| 2021-12-14 5:29 pm Purchase | 2021-12-10 | 13D | RESTORBIO INC TORC | ORBIMED ADVISORS LLC | 6,147,599 15.700% | 214,285 (+3.61%) | Filing History |
| 2021-12-06 4:25 pm Sale | 2021-12-02 | 13G | CTI BioPharma Corp. CTIC | ORBIMED ADVISORS LLC | 4,024,821 4.000% | -5,495,179 (-57.72%) | Filing History |
| 2021-11-18 5:10 pm Unchanged | 2021-11-15 | 13D | Theseus Pharmaceuticals, Inc. THRX | ORBIMED ADVISORS LLC | 16,838,668 43.500% | 0 (Unchanged) | Filing History |
| 2021-11-18 4:56 pm Sale | 2021-11-12 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 2,648,386 9.500% | -4,233,567 (-61.52%) | Filing History |
| 2021-11-12 5:05 pm Purchase | 2021-11-10 | 13D | Alpine Immune Sciences, Inc. ALPN | ORBIMED ADVISORS LLC | 4,226,843 14.400% | 1,010,637 (+31.42%) | Filing History |
| 2021-11-09 5:30 pm Purchase | 2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,071,547 18.400% | 5,357,143 (+42.13%) | Filing History |
| 2021-11-05 4:26 pm Purchase | 2021-11-05 | 13D | Sierra Oncology, Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 18.100% | 3,033,090 (+26006.64%) | Filing History |
| 2021-11-03 3:03 pm Unchanged | 2021-11-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 14.900% | 0 (Unchanged) | Filing History |
| 2021-11-02 5:01 pm Sale | 2021-11-01 | 13D | Repare Therapeutics Inc. RPTX | ORBIMED ADVISORS LLC | 3,177,041 7.700% | -99,284 (-3.03%) | Filing History |
| 2021-10-19 5:23 pm Purchase | 2021-10-12 | 13D | Theseus Pharmaceuticals, Inc. THRX | ORBIMED ADVISORS LLC | 16,838,668 44.900% | 16,838,668 (New Position) | Filing History |
| 2021-10-14 5:00 pm Sale | 2021-10-12 | 13G | Kala Pharmaceuticals, Inc. KALA | ORBIMED ADVISORS LLC | 0 0.000% | -188,568 (Position Closed) | Filing History |